台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    60.9
  • 漲跌
    ▲1.2
  • 漲幅
    +2.01%
  • 成交量
    158
  • 產業
    上櫃 生技醫療類股
  • 69人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
易威 (1799)籌碼相關-華南永昌-岡山 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

華南永昌-岡山 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/14161.3000.0062.9016210.16%
2025/01/13166.90266.0562.80-1627-0.16%
2025/01/10364.8300.0065.4036240.48%
2025/01/06263.0000.0065.1026230.32%
2024/12/2500.00174.2074.00-1683-0.15%
2024/12/2300.00166.1066.40-1680-0.15%
2024/12/1900.00263.7562.70-2695-0.29%
2024/12/112.154.9000.0054.902.16660.32%
2024/11/28165.2000.0064.8016720.15%
2024/11/2100.00367.9068.00-3662-0.45%
2024/11/1400.00166.3069.00-1670-0.15%
2024/11/13363.7700.0064.0036520.46%
2024/11/11170.1000.0070.1016060.16%
2024/11/082.178.8900.0077.802.16030.34%
2024/11/0600.00385.5385.20-3634-0.47%
2024/11/051.183.5800.0084.901.16360.16%
2024/11/04189.5000.0091.8016370.16%
2024/10/30194.1000.0093.8016700.15%
2024/10/181110.0000.00110.0017680.13%
2024/09/2500.001146.00147.50-1784-0.13%
2024/09/231160.001162.50158.0007940.00%
2024/09/135184.0000.00178.0057790.64%
2024/09/035220.0000.00217.0057970.63%
2024/08/2800.000.1220.71210.00-0.1788-0.02%
2024/08/2700.000220.77220.0007850.00%
2024/08/2600.000231.50226.0007900.00%
2024/08/2300.000226.50229.0007980.00%
2024/08/2200.000227.50221.5007980.00%
2024/08/2100.001.1224.81225.00-1.1802-0.13%
2024/08/2000.000212.72216.000806-0.01%
2024/08/1900.000197.88201.5008200.00%
2024/08/1600.000.1198.60200.50-0.1822-0.01%
2024/08/1500.000.1193.58191.50-0.1827-0.01%
2024/08/1400.000.1191.11192.00-0.1841-0.02%
2024/08/1300.000191.50189.0008430.00%
2024/08/1200.000203.75198.0008350.00%
2024/08/0900.000200.98203.5008240.00%
2024/08/0800.000184.00187.0007940.00%
2024/08/060173.000180.00171.0007770.00%
2024/08/0500.000186.50180.0007680.00%
2024/08/020176.001.1181.67177.50-1749-0.14%
2024/08/0100.001175.96175.50-1732-0.14%
2024/07/3100.000.1157.50161.00-0.1727-0.01%
2024/07/3000.000.1147.97148.00-0.1716-0.02%
2024/07/291149.500.2145.98141.500.87080.12%
2024/07/2600.000152.00148.0007000.00%
2024/07/221167.9800.00164.0016670.15%
2024/07/181198.000.1196.71196.500.96110.15%
2024/07/171189.000.2187.33191.000.95890.14%
2024/07/1600.000.1174.82174.50-0.1566-0.02%
2024/07/1200.000.1161.88162.00-0.1544-0.01%
2024/07/1000.000152.50152.5005120.00%
2024/07/0900.000.1139.00139.00-0.1499-0.02%
2024/07/040126.5000.00126.0004770.00%
2024/07/0300.000.1124.50124.50-0.1474-0.02%
2024/07/0100.000137.50137.5004350.00%
2024/06/2800.000124.00130.0004130.00%
2024/06/2700.000114.50118.5003930.00%
2024/06/130.398.2000.0096.000.33290.09%
2024/06/1100.001101.99101.50-1324-0.31%
2024/06/06095.5000.0095.0003180.01%
2024/06/0300.00092.8093.0003150.00%
2024/05/31091.5000.0091.8003170.01%
2024/05/30092.2100.0090.9003200.01%
2024/05/24099.5000.00105.0002980.00%
2024/05/220.193.2000.0091.500.12600.04%
2024/05/2000.00086.3086.300238-0.01%
2024/05/0900.00077.5078.000261-0.01%
2024/03/2000.000.159.5059.60-0.1226-0.04%
2024/03/08161.0000.0061.0012140.47%
2024/03/0100.00152.5054.80-1183-0.54%
2024/02/1500.000.855.0055.50-0.8177-0.47%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音